Healthdirect Free Australian health advice you can count on.
Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately
healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.
NSW Health Alert: Any patients who have received dental treatment from Dr William Kwok Hung Tam at Suite B, 2 Albert Road, Strathfield NSW 2135 may be at risk of blood-borne viruses and should see their GP for precautionary testing. More information is available from NSW Health.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Intragam® 10 is indicated for replacement IgG therapy in: Primary Immunodeficiency Diseases (PID) Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. Intragam® 10 is indicated for immunomodulatory therapy in: Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count Kawasaki disease Guillain-Barre Syndrome (GBS) Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Multifocal Motor Neuropathy (MMN) Myasthenia Gravis (MG) in acute exacerbation (myasthenic crisis) or prior to surgery and/or thymectomy; as maintenance therapy for moderate to severe MG when other treatments have been ineffective or caused intolerable side effects Short-term therapy for severely affected nonparaneoplastic Lambert-Eaton Myasthenic Syndrome (LEMS) patients Treatment of significant functional impairment in patients who have a verified diagnosis of stiff person syndrome.
Intragam® 10 is indicated for replacement IgG therapy in: Primary Immunodeficiency Diseases (PID) Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. Intragam® 10 is indicated for immunomodulatory therapy in: Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count Kawasaki disease Guillain-Barre Syndrome (GBS) Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Multifocal Motor Neuropathy (MMN) Myasthenia Gravis (MG) in acute exacerbation (myasthenic crisis) or prior to surgery and/or thymectomy; as maintenance therapy for moderate to severe MG when other treatments have been ineffective or caused intolerable side effects Short-term therapy for severely affected nonparaneoplastic Lambert-Eaton Myasthenic Syndrome (LEMS) patients Treatment of significant functional impairment in patients who have a verified diagnosis of stiff person syndrome.
Intragam® 10 is indicated for replacement IgG therapy in: Primary Immunodeficiency Diseases (PID) Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. Intragam® 10 is indicated for immunomodulatory therapy in: Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count Kawasaki disease Guillain-Barre Syndrome (GBS) Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Multifocal Motor Neuropathy (MMN) Myasthenia Gravis (MG) in acute exacerbation (myasthenic crisis) or prior to surgery and/or thymectomy; as maintenance therapy for moderate to severe MG when other treatments have been ineffective or caused intolerable side effects Short-term therapy for severely affected nonparaneoplastic Lambert-Eaton Myasthenic Syndrome (LEMS) patients Treatment of significant functional impairment in patients who have a verified diagnosis of stiff person syndrome.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
